Kange Corp   (KGNR)
Other Ticker:  
    Sector  Technology    Industry Software & Programming
   Industry Software & Programming
   Sector  Technology
Price: $0.8000 $0.74 1,150.000%
Day's High: $1 Week Perf: 56.86 %
Day's Low: $ 0.80 30 Day Perf:
Volume (M): 1 52 Wk High: $ 1.00
Volume (M$): $ 1 52 Wk Avg: $0.40
Open: $0.80 52 Wk Low: $0.01

 Market Capitalization (Millions $) 12
 Shares Outstanding (Millions) 14
 Employees 1
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 1
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Kange Corp
The Company is developing and marketing a software product as a mobile application for end users of the current generation iPhone and iPad from Apple, Inc., and mobile phones using the Android platform. The mobile application's digital content will be customizable by the owner of the particular device using our software. We plan to stay on the cutting edge of the constantly changing mobile application market, and our goal is to create a quality reputation within the mobile software community and marketplace. We plan to sell our initial applications through Apple's App Store or through our own online retail website to small business owners, who desire their own mobile applications and want to control the content. Apple, App Store, iPhone and iPad are trademarks of Apple Inc., and Android is a trademark of Alphabet Inc.

   Company Address: 11724 Ventura Blvd Suite B Studio City 91604 CA
   Company Phone Number: 853-7033   Stock Exchange / Ticker: KGNR
   KGNR is expected to report next financial results on January 20, 2022.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Meridian Bioscience Inc

EPS Drops, Sales Faded

In the fiscal time frame ending Jun 30 2021 Meridian Bioscience Inc earnings per share plummeted by -59.38% of $0.26 per share compared to $0.64 a year ago and profit plummeted by -56.67% from $0.60 per share from the previous quarter.

Sales crumbled by -25.1% to $63.51 millions from $84.80 millions in the same quarter a year ago and sequentially Sales fell by -25.51% from $85.26 millions.

Idexx Laboratories Inc

Surge in Sales and Earnings

Idexx Laboratories Inc announced strong results in the most recent fiscal period, where Sales rose by 29.57% to $826.14 millions and profits soared by 36.05 % to $2.34 per share, year on year.

Sequentially eps decreased by -0.43% from $2.35 per share and Sales increased by 6.23 % from $777.71 millions.



Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

MARZ's Profile

Stock Price

MARZ's Financials

Business Description


Charts & Quotes

MARZ's News


MARZ's Competitors

Customers & Markets

Economic Indicators

MARZ's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries






About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071